CS遗传学公司任命保罗·麦克尤恩为独立董事-动脉网

CS Genetics Appoints Paul McEwan as Independent Board Director

CISION 等信源发布 2025-04-29 02:02



可切换为仅中文







SAN DIEGO

圣迭戈

，

April 28, 2025

2025年4月28日

/PRNewswire/ -- CS Genetics, a leader in single cell genomics, is proud to announce the appointment of

/PRNewswire/ -- 单细胞基因组学领域的领导者CS Genetics自豪地宣布任命

Paul McEwan

保罗·麦克尤恩

as an Independent Director to its Board. Mr. McEwan brings over two decades of experience in life science tools, genomics, and strategic growth.

作为独立董事加入其董事会。麦克尤恩先生在生命科学工具、基因组学和战略增长方面拥有二十多年的经验。

Mr. McEwan is a serial entrepreneur in the life sciences sector, with a proven track record of founding and scaling innovative biotech companies. He co-founded Kapa Biosystems, serving as Chief Scientific Officer from 2006 until its acquisition by Roche in 2015. Under his leadership, Kapa Biosystems pioneered the use of directed evolution to develop high-performance reagents for life science applications..

麦克伊万先生是生命科学领域的连续创业者，拥有创立和扩展创新生物技术公司的成功记录。他共同创立了Kapa Biosystems，并自2006年起担任首席科学官，直到该公司于2015年被罗氏收购。在他的领导下，Kapa Biosystems率先利用定向进化技术开发用于生命科学应用的高性能试剂。

In addition to Kapa Biosystems, Mr. McEwan co-founded Agencourt Bioscience and Agencourt Personal Genomics. These ventures collectively achieved an exit value of over

除了Kapa Biosystems，麦克尤恩还共同创立了Agencourt Bioscience和Agencourt Personal Genomics。这些企业总共实现了超过

$700 million

7亿美元

, underscoring his ability to generate significant commercial and financial returns from venture-stage life-science companies.

，突显了他从初创阶段的生命科学公司产生显著商业和财务回报的能力。

Beyond his entrepreneurial ventures, Mr. McEwan is an active angel investor, focusing on early-stage companies in life science tools and diagnostics. He currently serves as Chairman of DNA Script and SeqWell, and as a Board Member of Watchmaker Genomics, Oligo Factory and Codetta Bio.

除了他的创业活动之外，麦克尤恩先生还是一位活跃的天使投资人，专注于生命科学工具和诊断领域的早期公司。他目前担任DNA Script和SeqWell的董事长，并且是Watchmaker Genomics、Oligo Factory和Codetta Bio的董事会成员。

'We are thrilled to welcome Paul to our Board of Directors,' said

“我们非常高兴欢迎保罗加入我们的董事会，”

Bill Colston

比尔·科尔斯顿

, CEO of CS Genetics. 'His extensive experience in genomics and strategic growth will be invaluable as we continue to advance our mission of democratizing single cell genomics.'

，CS Genetics首席执行官。“他在基因组学和战略增长方面的丰富经验将对我们继续推进单细胞基因组学民主化的使命带来巨大价值。”

About CS Genetics

关于CS遗传学

CS Genetics

计算机科学遗传学

is a privately held genomics-technology company based in

是一家私人持有的基因组学技术公司，总部位于

San Diego, California

加利福尼亚州圣地亚哥

. The company has developed a radically new, instrument-free platform for single-cell genomics with disruptive simplicity, speed, and scalability that will launch a new era of NGS-based cellular analysis. The company's technology leverages a molecular process known as Kinetic Confinement that is categorically different to other single cell technologies, and plugs seamlessly into standard, widespread lab infrastructure.

公司开发了一种全新的、无需仪器的单细胞基因组学平台，以其颠覆性的简便性、速度和可扩展性，将开启基于NGS的细胞分析新时代。该公司的技术利用了一种称为动力学限制的分子过程，这一过程与其他单细胞技术有本质不同，并且能够无缝接入标准且广泛使用的实验室基础设施。

The company holds a large global intellectual property estate covering its single cell platform and related reagent, workflow, manufacturing and application technologies. For more information, visit .

公司拥有涵盖其单细胞平台及相关试剂、工作流程、制造和应用技术的大型全球知识产权资产。欲了解更多信息，请访问。

www.csgenetics.com

。

Media Contact:

媒体联系人:

Matt Browning

马特·布朗宁

Director of Marketing

市场营销总监

CS Genetics, Inc.

CS遗传学公司

mbrowning@csgenetics.com